Monroe Capital Income Plus Corp 8-K
Research Summary
AI-generated summary
Monroe Capital Income Plus Corp Issues Shares; Declares $0.075 Dividend
What Happened
Monroe Capital Income Plus Corporation filed an 8-K on February 20, 2026 (Items 3.02 and 8.01) announcing an unregistered issuance of common stock and a board-declared cash distribution. On February 2, 2026 the company issued an aggregate 2,597,869 shares of common stock at $9.87 per share (finalized February 20, 2026) for total gross proceeds of $25,640,965, pursuant to subscription agreements and exempt from registration under Section 4(a)(2) and Regulation D or S. The board also declared a dividend of $0.075 per share to holders of record at the close of business on February 23, 2026, payable on or about February 25, 2026. The company reported its net asset value (NAV) per share as $9.87 as of January 31, 2026, per its valuation policy. The filing was signed by Lewis W. Solimene, Jr., Chief Financial Officer and Chief Investment Officer.
Key Details
- Issuance: 2,597,869 shares issued on Feb 2, 2026 at $9.87/share; aggregate offering price $25,640,965 (final share count determined Feb 20, 2026).
- Offering exemption: Shares sold under subscription agreements and exempt from Securities Act registration (Section 4(a)(2); Regulation D or S).
- Dividend: Board declared $0.075 per share to stockholders of record as of Feb 23, 2026; payment expected on or about Feb 25, 2026.
- NAV: Net asset value reported at $9.87 per share as of Jan 31, 2026.
Why It Matters
- Capital raise: The unregistered issuance generated about $25.6 million in gross proceeds, increasing the company’s equity base and providing cash that can be used to fund operations or investments.
- Share count and distributions: New shares increase outstanding common stock (potentially dilutive) while the declared dividend provides a near-term cash return to existing shareholders.
- NAV alignment: The offering price matched the reported NAV ($9.87), which is relevant for investors assessing relative valuation and dilution impact.
This summary covers the material items disclosed in the 8-K (Items 3.02 and 8.01) filed Feb 20, 2026.
Loading document...